133 related articles for article (PubMed ID: 6416848)
21. Relation of the neuroendocrine system to the development and growth of experimental mammary tumors.
Meites J
J Neural Transm; 1980; 48(1):25-42. PubMed ID: 6106045
[TBL] [Abstract][Full Text] [Related]
22. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
Bradley CJ; Kledzik GS; Meites J
Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
[TBL] [Abstract][Full Text] [Related]
23. Prophylaxis of early preneoplastic lesions of the mammary gland.
Welsch CW
Cancer Res; 1976 Jul; 36(7 PT 2):2621-5. PubMed ID: 1277169
[TBL] [Abstract][Full Text] [Related]
24. Changes in chromatin composition associated with hormone-dependent mammary tumor regression.
Goya RG; Sosa YE
Int J Cancer; 1983 Mar; 31(3):281-4. PubMed ID: 6402454
[TBL] [Abstract][Full Text] [Related]
25. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
Dauvois S; Spinola PG; Labrie F
Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
[TBL] [Abstract][Full Text] [Related]
26. Effects of diazoxide-induced reversible diabetes on chemically induced autochthonous mammary carcinomas in Sprague-Dawley rats.
Berger MR; Fink M; Feichter GE; Janetschek P
Int J Cancer; 1985 Mar; 35(3):395-401. PubMed ID: 3918948
[TBL] [Abstract][Full Text] [Related]
27. Correlation between hormone binding and growth response of rat mammary tumor.
Holdaway IM; Friesen HG
Cancer Res; 1976 May; 36(5):1562-7. PubMed ID: 817797
[TBL] [Abstract][Full Text] [Related]
28. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Pisarek H; Stepien H; Pawlikowski M
Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
[TBL] [Abstract][Full Text] [Related]
29. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
Gandilhon P; Mélançon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
[TBL] [Abstract][Full Text] [Related]
30. Prolactin levels and molecular heterogeneity in rat strains with high and low incidence of DMBA-induced mammary tumors.
Lawson DM; Sensui N; Haisenleder DH; Kaufman PN; Gala RR
Breast Cancer Res Treat; 1984; 4(2):129-36. PubMed ID: 6430370
[TBL] [Abstract][Full Text] [Related]
31. Effect of continuous light on the incidence of 9,10-dimethyl-1,2-benzanthracene induced mammary tumors in female Holtzman rats.
Kothari LS; Shah PN; Mhatre MC
Cancer Lett; 1982 Sep; 16(3):313-7. PubMed ID: 6817910
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.
Flückiger E; Briner U; Clark B; Closse A; Enz A; Gull P; Hofmann A; Markstein R; Tolcsvai L; Wagner HR
Experientia; 1988 May; 44(5):431-6. PubMed ID: 3371446
[TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats.
Zaccheo T; Giudici D; Di Salle E
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):677-80. PubMed ID: 8476783
[TBL] [Abstract][Full Text] [Related]
34. Antineoplastic properties of Maharishi-4 against DMBA-induced mammary tumors in rats.
Sharma HM; Dwivedi C; Satter BC; Gudehithlu KP; Abou-Issa H; Malarkey W; Tejwani GA
Pharmacol Biochem Behav; 1990 Apr; 35(4):767-73. PubMed ID: 2140606
[TBL] [Abstract][Full Text] [Related]
35. Influence of underfeeding during the "critical period" or thereafter on carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1982 Dec; 42(12):4943-7. PubMed ID: 6814746
[TBL] [Abstract][Full Text] [Related]
36. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.
Tamarkin L; Cohen M; Roselle D; Reichert C; Lippman M; Chabner B
Cancer Res; 1981 Nov; 41(11 Pt 1):4432-6. PubMed ID: 6796259
[TBL] [Abstract][Full Text] [Related]
37. Modification of the effect of a gonadoliberin analog on 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by hormone replacement.
Rose DP; Pruitt B
Cancer Res; 1979 Oct; 39(10):3968-70. PubMed ID: 113083
[TBL] [Abstract][Full Text] [Related]
38. Prolactin binding to dissociated cells from rat mammary tumors and mammary gland.
Smith RD; Hilf R; Senior AE
Cancer Biochem Biophys; 1979; 3(3):117-21. PubMed ID: 121922
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.
Zaccheo T; Giudici D; Ornati G; Panzeri A; di Salle E
Eur J Cancer; 1991; 27(9):1145-50. PubMed ID: 1835626
[TBL] [Abstract][Full Text] [Related]
40. Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin.
Rose DP; Gottardis M; Noonan JJ
Anticancer Res; 1983; 3(5):323-5. PubMed ID: 6139974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
